Horizant (Arbor Pharmaceuticals)


Welcome to the PulseAid listing for the Horizant drug offered from Arbor Pharmaceuticals. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Arbor Pharmaceuticals
NON-PROPRIETARY NAME: gabapentin enacarbil
SUBSTANCE NAME: GABAPENTIN ENACARBIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-05-01
END MARKETING DATE: 0000-00-00


Horizant HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHorizant from Arbor Pharmaceuticals
LABELER NAME: Arbor Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/1)
START MARKETING DATE: 2013-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53451-0101_58396e1f-c1f4-460b-af3e-30827f69cc24
PRODUCT NDC: 53451-0101
APPLICATION NUMBER: NDA022399

Other GABAPENTIN ENACARBIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Arbor PharmaceuticalsHorizant
REMEDYREPACK INC.Horizant